Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease

Ming-Jui Hung; Wen-Jin Cherng; Chi-Wen Cheng; Ning-I Yang

doi:10.1016/j.amjcard.2004.08.064

Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease

Am J Cardiol. 2005 Jan 1;95(1):84-7. doi: 10.1016/j.amjcard.2004.08.064.

Authors

Ming-Jui Hung¹, Wen-Jin Cherng, Chi-Wen Cheng, Ning-I Yang

Affiliation

¹ Cardiology Section, Department of Medicine, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan. miran888@ms61.hinet.net <miran888@ms61.hinet.net>

PMID: 15619396
DOI: 10.1016/j.amjcard.2004.08.064

Abstract

Levels of high-sensitivity C-reactive protein were measured before and after 3 months of treatment with antispastic agents (calcium antagonists and/or isosorbide dinitrate) in 27 patients who had coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. Levels of high-sensitivity C-reactive protein decreased after treatment with antispastic agents.

MeSH terms

Angina Pectoris / drug therapy*
Angina Pectoris / etiology
Angina Pectoris / physiopathology*
C-Reactive Protein / drug effects*
Calcium Channel Blockers / pharmacology*
Calcium Channel Blockers / therapeutic use
Coronary Disease / complications
Coronary Disease / physiopathology
Coronary Vasospasm / complications
Coronary Vasospasm / drug therapy*
Female
Hemodynamics
Humans
Isosorbide Dinitrate / pharmacology*
Isosorbide Dinitrate / therapeutic use
Male
Middle Aged
Parasympatholytics / pharmacology*
Parasympatholytics / therapeutic use

Substances

Calcium Channel Blockers
Parasympatholytics
C-Reactive Protein
Isosorbide Dinitrate